Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 11, 2020

SELL
$6.5 - $10.73 $940,056 - $1.55 Million
-144,624 Closed
0 $0
Q3 2019

Nov 12, 2019

SELL
$8.75 - $12.85 $2.71 Million - $3.98 Million
-309,676 Reduced 68.17%
144,624 $1.56 Million
Q2 2019

Aug 12, 2019

SELL
$12.3 - $35.76 $1.43 Million - $4.17 Million
-116,500 Reduced 20.41%
454,300 $5.77 Million
Q1 2019

May 07, 2019

BUY
$20.77 - $42.37 $2.01 Million - $4.1 Million
96,700 Added 20.4%
570,800 $22.1 Million
Q4 2018

Feb 12, 2019

BUY
$20.07 - $46.7 $7.81 Million - $18.2 Million
389,000 Added 457.11%
474,100 $9.65 Million
Q2 2018

Aug 08, 2018

BUY
$48.3 - $68.25 $4.11 Million - $5.81 Million
85,100 New
85,100 $5.03 Million
Q1 2018

May 10, 2018

SELL
$59.7 - $99.25 $1.18 Million - $1.96 Million
-19,700 Closed
0 $0
Q4 2017

Feb 12, 2018

BUY
$93.85 - $132.45 $1.85 Million - $2.61 Million
19,700
19,700 $1.95 Million

Others Institutions Holding PBYI

About PUMA BIOTECHNOLOGY, INC.


  • Ticker PBYI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,556,000
  • Market Cap $132M
  • Description
  • Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...
More about PBYI
Track This Portfolio

Track Spark Investment Management LLC Portfolio

Follow Spark Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spark Investment Management LLC with notifications on news.